Sceptrin-Au nano-aggregates (SANA) for overcoming drug-resistant Gram-negative bacteria

Jong Min An, Sangrim Kang, Chang Woo Koh, Sungnam Park, Myung Sook Oh, Dokyoung Kim

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


One of the recent advances in medical nanotechnology has been the development of nanoformulations to overcome drug-resistant bacterial infections. Herein, we disclose a new nano-antibiotic formulation based on sceptrin-Au nano-aggregates (SANA), which are drug-metal ion multiple complexes. Sceptrin is a natural compound from a marine organism (sponge) and was reported as a potential compound with drug activities. SANA consists of a sceptrin-Au ion and is a self-assembled nano-formation with electrostatic interaction. Interestingly, SANA showed superior antibiotic/antibiofilm activity toward carbapenem-resistant Gram-negative bacteria with low toxicity to red blood cells and endothelial cells. The working mechanism of SANA was identified with analysis of the extracellular reactive oxygen species level and membrane depolarization of bacteria. The feasibility of SANA as a new nano-antibiotic was demonstrated in CRPA-contaminated medical supplies where SANA inhibited the formation of biofilms as well as the growth of CRPA. This work presents a new concept for the development of next-generation nano-antibiotics and a more feasible clinical translational pathway.

Original languageEnglish
Pages (from-to)873-882
Number of pages10
JournalNanoscale horizons
Issue number8
Publication statusPublished - 2022 Jul 1

ASJC Scopus subject areas

  • Materials Science(all)


Dive into the research topics of 'Sceptrin-Au nano-aggregates (SANA) for overcoming drug-resistant Gram-negative bacteria'. Together they form a unique fingerprint.

Cite this